SOD2 and polycystic ovary syndrome: PCOS had decreased catalase mRNA expression compared to controls (− 1.15 ± 0.38 vs 0.00 ± 0.22, P < 0.05), though SOD1 and SOD2 were unchanged in mWAT in PCOS model (Fig. 3G–I).